Phospholipid compounds and formulations
US11464792B2 · kind B2 · utility
0Cited by
3References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 22, 2021 |
| Grant date | Oct 11, 2022 |
| Priority date | — |
| Expiry date | Jan 22, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/663
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides phospholipid-containing compounds, pharmaceutical compositions and microspheres that exhibit high affinity for mineralized metals. The present disclosure also provides strategies for using said compounds, compositions and microspheres in the treatment of nephrolithiasis or kidney stone disease, and methods of manufacturing and preparing said compounds and compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.